CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-29 | Huang Jane CMO, Hematology | Sale | −100 | $301.51 | $30K | 0 |
| 2020-10-29 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −19,500 | 363,575 | ||
| 2020-10-16 | Wang Xiaodong Director | Sale | −5,000 | $320.00 | $1.6M | 0 |
| 2020-10-13 | BAKER BROS. ADVISORS LP Director | Gift | −13,516 | 10,418 | ||
| 2020-10-13 | BAKER BROS. ADVISORS LP Director | Gift | −13,516 | 10,418 | ||
| 2020-10-05 | Wang Xiaodong Director | Sale | −5,000 | $300.00 | $1.5M | 0 |
| 2020-10-05 | Wu Xiaobin President & GM China | Sale | −4,000 | $300.00 | $1.2M | 0 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Option exercise | +14,000 | $6.50 | $91K | 14,000 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −817 | $293.26 | $240K | 13,183 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −1,415 | $294.92 | $417K | 11,768 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −568 | $295.73 | $168K | 11,200 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −500 | $296.47 | $148K | 10,700 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −1,200 | $297.98 | $358K | 9,500 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −1,000 | $298.97 | $299K | 8,500 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −2,001 | $300.08 | $600K | 6,499 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −1,499 | $300.88 | $451K | 5,000 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −2,831 | $302.11 | $855K | 2,169 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −1,869 | $303.24 | $567K | 300 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Sale | −300 | $304.15 | $91K | 0 |
| 2020-10-05 | Liang Howard CFO & Chief Strategy Officer | Option exercise · Stock Option (Right to Buy) | −182,000 | 3,431,000 |
Page 77 of 99 · 1,972 trades